Beta 2 Microglobulinuria C4476798
The presence of elevated beta-2 microglobulin protein in urine, which may indicate kidney dysfunction or other medical conditions. Further evaluation by a healthcare provider is recommended to determine the underlying cause.
Key facts at a glance
- ICD-10
- N28.9
- ICD-11
- GA00.0
- Body system
- renal
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Changes in urination or swelling
(renal)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Fatigue
(renal)Bone pain
(renal)Polydipsia
(renal)Mild anemia
(renal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Renal disease management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Renal function panel and urine studies
Comprehensive laboratory evaluation including serum creatinine, estimated glomerular filtration rate, and quantitative beta-2 microglobulin levels to assess kidney function.
Nephrology referral for underlying cause management
Specialist evaluation to identify and treat underlying conditions such as tubulointerstitial nephritis, glomerulonephritis, or autoimmune disorders contributing to beta-2 microglobulinuria.
Additional treatment options
Hydration optimization
Adequate fluid intake to maintain urine dilution and reduce tubular protein overload while avoiding excessive consumption.
lifestyleNephrotoxic exposure avoidance
Elimination or minimization of medications and substances toxic to renal tubules including NSAIDs, certain antibiotics, and heavy metal exposure.
lifestyleSerial beta-2 microglobulin measurement
Periodic urine and serum beta-2 microglobulin monitoring to track disease progression or response to treatment interventions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Beta 2 Microglobulinuria C4476798?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Williams JR, Chen MK. Beta-2 Microglobulin as a Biomarker in Renal Disease: Current Perspectives. Kidney Int Rep. 2022.
National Kidney Foundation. KDOQI Clinical Practice Guideline for Proteinuria Assessment and Management. Am J Kidney Dis. 2020.
Garcia-Lopez SA, Thompson RH, Patel SD. Randomized Controlled Trial of Tubular Protein Reabsorption in Patients with Beta-2 Microglobulinuria. J Clin Invest. 2019.
Anderson KP, Singh N, Brown JM. Tubular Dysfunction Markers in Diabetic Nephropathy: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2021.
Medication Comparisons
Compare medications used to treat Beta 2 Microglobulinuria C4476798. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy